日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The choice of serum-free light chain analysis method could potentially have clinical consequences for myeloma patients

血清游离轻链分析方法的选择可能对多发性骨髓瘤患者产生临床影响。

期刊:eJHaem
影响因子:1.2
doi:10.1002/jha2.886
Veskovski, Ljupco; Jakobsson, Ingvar; Andersson, Per-Ola; Gustafsson, Therese; Sedigh, Annelie; Knut-Bojanowska, Dorota; Hansson, Markus; Hveding Blimark, Cecilie; Mellqvist, Ulf-Henrik
多发性骨髓瘤
骨髓瘤
发表日期：2024
文献求助 收藏

Regional differences in treatment and outcome for myeloma patients in Sweden: A population based Swedish myeloma register study

瑞典多发性骨髓瘤患者治疗和预后的区域差异：一项基于瑞典多发性骨髓瘤登记研究

期刊:Cancer Reports
影响因子:1.9
doi:10.1002/cnr2.1614
Wålinder, Göran; Genell, Anna; Juliusson, Gunnar; Svensson, Ronald; Santamaria, Antonio Izarra; Crafoord, Jacob; Carlson, Kristina; Knut-Bojanowska, Dorota; Veskovski, Ljupco; Lauri, Birgitta; Lund, Johan; Turesson, Ingemar; Hansson, Markus; Blimark, Cecilie Hveding; Nahi, Hareth
多发性骨髓瘤
骨髓瘤
发表日期：2022
文献求助 收藏

Sequence variation at the MTHFD1L-AKAP12 and FOPNL loci does not influence multiple myeloma survival in Sweden

MTHFD1L-AKAP12 和 FOPNL 位点的序列变异并不影响瑞典多发性骨髓瘤患者的生存率。

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-019-0222-8
Ali, Mina; Lemonakis, Konstantinos; Wihlborg, Anna-Karin; Veskovski, Ljupco; Turesson, Ingemar; Mellqvist, Ulf-Henrik; Gullberg, Urban; Hansson, Markus; Nilsson, Björn
多发性骨髓瘤
骨髓瘤
发表日期：2019
文献求助 收藏